- 2025-2026
- 2024-2025
- 2023-2024
- 2022-2023
- 2021-2022
- 2020-2021
- 2019-2020
- 2018-2019
- 2017-2018
- 2016-2017
- 2015-2016
2025-2026
-
31 October 2025 TR1 Notification
-
31 October 2025 TR1 Notification
-
13 October 2025 Final Results
-
25 September 2025 Visiclean Product Launch
-
11 September 2025 Issue of Equity
-
1 Sept 2025 Confirmation of CFO
-
18 August 2025 Issue of Equity
-
6 August 2025 Capital Markets Day 2025
-
29 July 2025 Trading Update
-
24 July 2025 Confirmation of investor presentations
-
17 July 2025 CFO Appointment
-
4 July 2025 TR1 Notification
-
26 June 2025 APIC25 Annual Conference attendance
-
21 August 2025 TR1 Notification
-
2024-2025
-
26 June 2025 APIC25 Annual Conference attendance
-
2 June 2025 Investor Presentations and Notice of Trading Update
-
30 May 2025 TR1 Notification
-
28 May 2025 Mello attendence
-
16 May 2025 Issue of Equity
-
15 May 2025 CFO Succession planning
-
12 May 2025 FDA clearance for Tristel OPH
-
10 April 2025 Tristel OPH Update - FDA submission
-
9 April 2025 Publication of paper
-
1 April 2025 Director PDMR Shareholding
-
28 March 2025 TR1 Notification
-
26 March 2025 Director PDMR Shareholding
-
18 March 2025 TR1 Notification
-
Tristel Interim Result 2025
-
07 February Issue of Equity
-
23 January Grant of Options
-
13 January 2024 Confirmation of Results
-
16 December 2024 Result of AGM
-
16 December 2024 AGM Statement
-
22 November 2024 Notice of AGM
-
20 November 2024 Issue of Equity
-
14 November 2024 Issue of Equity
-
28 October 2024 Exercise of Share Options and Total Voting Rights
-
21 October 2024 Preliminary Results
-
1 October 2024 Notice of Preliminary Result
-
19 September 2024 Director PDMR Shareholding
-
19 September 2024 Issue of Equity
-
12 September 2024 FDA submission - Tristel OPH
-
2 September 2024 CEO Transition and Directorate Change
-
06 August 2024 Issue of Equity
-
22 July 2024 Trading Update
-
4 July 2024 Exercise of Share Options and Total Voting Rights
-
2023-2024
-
11 June 2024 TR1 notification
-
11 June 2024 Director PDMR Shareholding
-
10 June 2024 Directorate Changes - Appointment of CEO
-
8 May 2024 Tristel ULT Case Study
-
7 May 2024 Issue of Equity
-
16 April 2024 Director PDMR Shareholding
-
16 April 2024 Issue of Equity
-
19 March 2024 Issue of Equity
-
26 February 2024 Issue of Equity
-
26 February 2024 Half-year Report
-
26 February 2024 Cache MDR approvals
-
08 February 2024 Issue of Equity
-
01 February 2024 Notice of Results
-
25 January 2024 Issue of Equity
-
23 January 2024 Tristel ULT Canada approval
-
10 January 2024 Director PDMR Shareholding
-
19 December 2023 Result of AGM
-
19 December 2023 AGM Statement 2023
-
07 December 2023 Issue of Equity
-
01 December 2023 Issue of Equity
-
29 November 2023 Issue of Equity
-
7 November 2023 Issue of Equity
-
16 October 2023 Preliminary Results
-
16 October 2023 Investor Presentation
-
12 October 2023 Additional Investor Presentation
-
10 October 2023 Issue of Equity
-
02 October 2023 TR-1 Standard form for notification of major holdings
-
28 September 2023 Exercise of Share Options and Total Voting Rights
-
27 September 2023 TR-1 Standard form for notification of major holdings
-
26 September 2023 TR-1 Standard form for notification of major holdings
-
23 September 2023 TR-1 Standard form for notification of major holdings
-
12 September 2023 Notice of results
-
04 September 2023 Health Canada regulatory approval submission for Tristel ULT
-
28 July 2023 TR-1 Standard form for notification of major holdings
-
28 July 2023 Director PDMR Shareholding
-
25 July 2023 Trading Update
-
12 July 2023 Shareholder Open Day 2023
-
07 July 2023 Issue of Equity
-
2022-2023
-
26 June 2023 Director / PDMR Shareholding
-
23 June 2023 TR-1: Standard form for notification of major holdings
-
16 June 2023 Issue of Equity
-
14 June 2023 TR-1: Standard form for notification of major holdings
-
07 June 2023 Issue of Equity
-
05 June 2023 Investor Presentation Details
-
05 June 2023 Tristel ULT FDA classification
-
28 March 2023 Issue of Equity
-
27 March 2023 FDA RAI Submission
-
14 March 2023 Issue of Equity
-
23 February 2023 Issue of Equity
-
20 February 2023 Interim Results Investor Presentation 2023
-
20 February 2023 Half year Report 2023
-
23 January 2023 Notice of Results
-
13 December 2022 Issue of Equity
-
12 December 2022 Results of AGM
-
12 December 2022 AGM Statement 2022
-
02 November 2022 TR-1: Standard form for notification of major holdings
-
25 October 2022 Preliminary Results
-
04 October 2022 Company Secretary appointment
-
04 October 2022 Notice of Results
-
29 September 2022 North America Update
-
22 July 2022 Director / PDMR Shareholding
-
18 July 2022 Trading update and special dividend
-
18 July 2022 TR-1: Standard form for notification of major holdings
-
2021-2022
-
30 June 2022 De Novo FDA submission for Tristel Duo ULT
-
20 June 2022 Tristel Open Day 2022
-
07 June 2022 TR-1: Standard form for notification of major holdings
-
04 May 2022 Investor Presentation
-
03 May 2022 TR-1: Standard form for notification of major holdings
-
14 April 2022 Issue of Equity
-
06 Apr 2022 Director / PDMR Shareholding
-
05 April 2022 Director / PDMR Shareholding
-
29 March 2022 Director / PDMR Shareholding
-
23 February 2022 Confirmation of dividend
-
22 February 2022 Director / PDMR Shareholding
-
21 February 2022 Half Year Report 2022
-
17 February 2022 Exercise of options
-
01 February 2022 Confirmation of Results
-
13 December 2021 Result of AGM
-
13 December 2021 AGM Statement
-
27 October 2021 Director / PDMR Shareholding
-
22 October 2021 Director / PDMR Shareholding
-
20 October 2021 TR-1: Standard form for notification of major holdings
-
19 October 2021 Issue of Equity
-
18 October 2021 Director / PDMR Shareholding
-
18 October 2021 Preliminary Results 2021
-
13 October 2021 TR1 Notification
-
10 August 2021 Issue of Equity
-
30 July 2021 TR-1: Standard form for notification of major holdings
-
21 July 2021 Trading Update
-
08 July 2021 Issue of Equity
-
2020-2021
-
24 June 2021 Regulatory Approvals
-
07 June 2021 Issue of Equity
-
26 April 2021 Trading Update
-
19 April 2021 Issue of Equity
-
06 April 2021 Director PDMR Shareholding
-
26 March 2021 Issue of Equity
-
03 March 2021 Director PDMR Shareholding
-
02 March 2021 PDMR Issue of Equity
-
22 February 2021 Half Year Report
-
18 February 2021 Notice of Investor Presentation
-
27 January 2021 Issue of Equity
-
18 January 2021 Issue of Equity
-
24 December 2020 Director Appointment
-
15 December 2020 Result of AGM
-
15 December 2020 AGM Statement
-
02 December 2020 Update to Executive Performance Share Plan 2021
-
02 December 2020 AIM Award RNS Reach
-
09 November 2020 Issue of Equity
-
02 November 2020 QA Update following preliminary results
-
27 October 2020 Issue of Equity
-
19 October 2020 Final Results
-
19 October 2020 Dividend Timetable
-
06 October 2020 Notice of results
-
05 October 2020 Issue of Equity
-
01 October 2020 Investor Presentation 2020
-
04 September 2020 Issue of Equity
-
21 August 2020 RNS Reach - India Regulatory Approval
-
07 August 2020 Issue of Equity
-
06 August 2020 Open Day QA RNS Reach
-
22 July 2020 RNS Reach - Trading Update
-
22 July 2020 PDMR Issue of Equity
-
2019-2020
-
23 June 2020 Notice of trading update, Results and investors presentation
-
05 June 2020 Issue of Equity
-
05 June 2020 AIM Application Form
-
22 May 2020 Issue of Equity
-
28 April 2020 Issue of Equity
-
27 April 2020 Director appointment
-
09 April 2020 Issue of Equity
-
07 April 2020 Issue of Equity
-
31 March 2020 TR-1: Standard form for notification of major holdings
-
25 March 2020 TR-1: Standard form for notification of major holdings
-
23 March 2020 Byotrol plc agreement
-
12 March 2020 Issue of Equity
-
10 March 2020 Issue of Equity
-
06 March 2020 TR-1: Standard form for notification of major holdings
-
03 March 2020 PDMR Issue of equity
-
25 February 2020 PDMR / Director Shareholding
-
24 February 2020 Interim Statement 2020
-
20 February 2020 Issue of Equity
-
10 February 2020 Issue of Equity
-
30 January 2020 Issue of Equity
-
15 January 2020 RNS Reach - Investor Presentation
-
14 January 2020 Issue of Equity
-
17 December 2019 Result of AGM
-
17 December 2019 AGM Statement Notice of Results
-
04 December 2019 Issue of Equity
-
03 December 2019 Holding(s) in Company
-
26 November 2019 Forthcoming Appointment of Non-Executive Chairman
-
20 November 2019 Issue of Equity
-
18 November 2019 TSTL MODT 2nd Round Funding
-
01 November 2019 Issue of Equity
-
01 November 2019 Audited accounts and notice of AGM
-
18 October 2019 Issue of Equity
-
16 October 2019 Prelims RNS
-
13 September 2019 Issue of Equity
-
10 September 2019 Holding(s) in Company
-
02 September 2019 Issue of Equity
-
21 August 2019 RNS - Investor results presentation
-
08 August 2019 Issue of Equity
-
01 August 2019 TR-1 Francisco Soler (market notification)
-
22 July 2019 Trading update Acquisition Notice of Results
-
2018-2019
-
05 June 2019 Shareholder Open Day 2019
-
17 May 2019 Issue of Equity
-
14 May 2019 TR-1 Francisco Soler (market notification)
-
01 April 2019 RNS Reach - Product Approvals
-
26 March 2019 TR-1 Francisco Soler (market notification)
-
06 March 2019 Issue of Equity
-
05 March 2019 Deferred Consideration
-
01 March 2019 Director / PDMR Shareholding
-
25 February 2019 Interim Statement
-
04 February 2019 Director Appointment Bruno Holthof
-
14 January 2019 RNS Reach - Investors Presentations
-
14 January 2019 Director Shareholding
-
11 December 2018 Result of AGM
-
11 December 2018 AGM Statement
-
19 November 2018 Ecomed acquisition RNS
-
19 November 2018 Director PDMR Shareholding
-
09 November 2018 Issue of Equity
-
17 October 2018 Final results RNS
-
13 September 2018 Notice of results
-
24 August 2018 Issue of Equity
-
23 August 2018 Issue of Equity
-
17 July 2018 TR-1: Standard form for notification of major holdings
-
16 July 2018 Proposed secondary placing of ordinary shares in Tristel
-
13 July 2018 Trading Update Notice of Results
-
2017-2018
-
12 June 2018 Issue of Equity
-
08 June 2018 Tristel Open Day 2018
-
08 June 2018 PDMR Dealing
-
07 June 2018 Issue of Equity
-
24 May 2018 PDMR Dealing
-
15 May 2018 TR-1 Standard form for notification of major holdings
-
11 May 2018 PDMR Dealing Issue of Equity
-
10 May 2018 TR-1: Standard form for notification of major holdings
-
08 May 2018 Issue of Equity
-
03 May 2018 Issue of Equity
-
23 April 2018 EPA approval received
-
19 April 2018 Issue of Equity
-
29 March 2018 Issue of Equity
-
26 March 2018 Commercial collaboration with Parker Laboratories Inc
-
14 March 2018 Issue of Equity
-
20 February 2018 Interim Results RNS
-
09 February 2018 Tristel Holdings in Company
-
24 January 2018 RNS Reach Singapore
-
23 January 2018 Issue of Equity
-
17 January 2018 RNS - Investor Presentation
-
12 December 2017 AGM Statement 2017
-
23 November 2017 Clarification of AGM timing
-
13 November 2017 Issue of Equity
-
02 November 2017 Share Option Scheme 2017
-
19 October 2017 Issue of Equity
-
19 October 2017 Final Results
-
19 October 2017 Director Appointment
-
03 October 2017 EPA update
-
18 September 2017 Issue of Equity
-
21 August 2017 Issue of Equity
-
19 August 2017 Investor Results Presentation
-
16 August 2017 PDMR Dealing
-
04 August 2017 Issue of Equity
-
24 July 2017 Issue of Equity
-
19 July 2017 Tristel Open Day Trading update
-
19 July 2017 Investor Open Day Presentation & Script 2017
-
03 July 2017 RNS - USA incorporation EPA
-
03 July 2017 RNS - Mobile ODT
-
03 July 2017 Issue of Equity
-
2016-2017
-
16 June 2017 Issue of Equity
-
24 May 2017 Tristel Open Day
-
19 May 2017 Issue of Equity
-
03 May 2017 Issue of Equity
-
07 April 2017 Result of Placing
-
07 April 2017 Proposed Secondary Placing
-
24 March 2017 Issue of Equity
-
07 March 2017 Issue of Equity
-
06 March 2017 Issue of Equity
-
27 February 2017 TGA approval Stella and Jet Liquid
-
27 February 2017 Australia and World Ultrasound
-
23 February 2017 Interim Results RNS
-
25 January 2017 Investor Results Presentation
-
24 January 2017 Journal of Infection Prevention
-
13 December 2016 AGM Statement
-
06 December 2016 Issue of Equity
-
28 November 2016 Notice of AGM correction
-
23 November 2016 Issue of Equity
-
17 October 2016 Tristel plc Group RNS Final
-
13 October 2016 Issue of Equity
-
11 October 2016 RNS Reach - Journal of Laryngology Otology
-
20 September 2016 Notice of Results & Investor Results Presentations
-
19 September 2016 Issue of Equity
-
12 September 2016 TSTL Australia approval
-
19 August 2016 Issue of Equity
-
22 July 2016 Director Dealing - David Orr
-
21 July 2016 Trading Update Acquisition Special Dividend
-
2015-2016
-
25 May 2016 Shareholder Open Day 2016
-
29 April 2016 Director Dealing
-
26 April 2016 Director Dealing
-
14 March 2016 Director Dealing
-
10 March 2016 Director Dealing
-
09 March 2016 Director Dealing
-
02 March 2016 Director Dealing
-
01 March 2016 Director Dealing
-
26 February 2016 Director Dealings
-
26 February 2016 Director Dealing
-
24 February 2016 Interim Results
-
25 January 2016 Notice of Results
-
13 January 2016 Issue of Equity
-
05 January 2016 RNS Reach - German branch to subsidiary status
-
15 December 2015 Result of AGM
-
15 December 2015 Directors Dealings
-
15 December 2015 AGM Statement
-
02 December 2015 Issue of equity
-
01 December 2015 RNS Reach French Study
-
01 December 2015 Posting of AR Notice of AGM
-
02 November 2015 Issue of Equity
-
21 October 2015 Issue of Equity
-
15 October 2015 Issue of Equity and DD
-
12 October 2015 Prelim Year End 2015
-
05 October 2015 Change of Venue
-
01 October 2015 Board Appointment
-
24 September 2015 Issue of Equity
-
18 September 2015 Notice of Results
-
18 August 2015 Issue of Equity
-
17 August 2015 Director Share Transfer
-
06 August 2015 Issue of Equity
-
04 August 2015 Grant of Options
-
20 July 2015 Issue of Equity
-